KYNTRA BIO, INC. Tax Withholding Paid on Stock Awards
KYNTRA BIO, INC. (KYNB) reported Tax Withholding Paid on Stock Awards of $12.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-13
- KYNTRA BIO, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $5.00K, a 58.33% decline year-over-year.
- KYNTRA BIO, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $7.00K, a 81.08% decline year-over-year.
- KYNTRA BIO, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $8.00K, a 42.86% decline year-over-year.
- KYNTRA BIO, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $12.00K, a 89.19% decline year-over-year.
- KYNTRA BIO, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $69.00K, a 80.51% decline from fiscal 2024.
- KYNTRA BIO, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $354.00K, a 49.37% increase from fiscal 2023.
- KYNTRA BIO, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $237.00K, a 95.41% decline from fiscal 2022.
- KYNTRA BIO, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $5.17M, a 29.91% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $12.00K 10-Q · filed 2026-08-13 | $20.00K derived: sum of 3 quarters · filed 2026-08-13 | $32.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $7.00K 10-Q · filed 2026-05-12 | $15.00K derived: sum of 2 quarters · filed 2026-05-12 | $27.00K derived: sum of 3 quarters · filed 2026-05-12 | $39.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $20.00K derived: sum of 2 quarters · filed 2026-03-16 | $32.00K derived: sum of 3 quarters · filed 2026-08-13 | $69.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $24.00K derived: sum of 2 quarters · filed 2026-08-13 | $61.00K 10-Q · filed 2025-11-10 | $75.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $49.00K 10-Q · filed 2026-08-13 | $63.00K derived: sum of 3 quarters · filed 2026-08-13 | $174.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $37.00K 10-Q · filed 2026-05-12 | $51.00K derived: sum of 2 quarters · filed 2026-05-12 | $162.00K derived: sum of 3 quarters · filed 2026-05-12 | $238.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $125.00K derived: sum of 2 quarters · filed 2026-03-16 | $201.00K derived: sum of 3 quarters · filed 2026-03-16 | $354.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $187.00K derived: sum of 2 quarters · filed 2025-11-10 | $340.00K 10-Q · filed 2025-11-10 | $577.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $229.00K 10-Q · filed 2025-08-11 | $466.00K derived: sum of 3 quarters · filed 2025-08-11 | $466.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $153.00K 10-Q · filed 2025-05-12 | $390.00K derived: sum of 2 quarters · filed 2025-05-12 | $390.00K derived: sum of 3 quarters · filed 2025-05-12 | $390.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $237.00K derived: sum of 2 quarters · filed 2025-03-17 | $237.00K derived: sum of 3 quarters · filed 2025-03-17 | $237.00K 10-K · filed 2025-03-17 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $605.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $605.00K derived: sum of 3 quarters · filed 2024-08-06 | $1.81M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-06 | $605.00K derived: sum of 2 quarters · filed 2024-05-06 | $1.81M derived: sum of 3 quarters · filed 2024-05-06 | $2.19M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $1.81M derived: sum of 2 quarters · filed 2024-02-26 | $2.19M derived: sum of 3 quarters · filed 2024-02-26 | $5.17M 10-K · filed 2024-02-26 |
| 2022-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.59M derived: sum of 2 quarters · filed 2023-11-06 | $4.56M 10-Q · filed 2023-11-06 | $5.20M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $387.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $3.36M 10-Q · filed 2023-08-07 | $4.00M derived: sum of 3 quarters · filed 2024-02-26 | $4.80M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $2.97M 10-Q · filed 2023-05-08 | $3.61M derived: sum of 2 quarters · filed 2024-02-26 | $4.42M derived: sum of 3 quarters · filed 2024-02-26 | $5.59M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $638.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $1.44M derived: sum of 2 quarters · filed 2024-02-26 | $2.62M derived: sum of 3 quarters · filed 2024-02-26 | $7.37M 10-K · filed 2024-02-26 |
| 2021-09-30 | $806.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.98M derived: sum of 2 quarters · filed 2022-11-07 | $6.73M 10-Q · filed 2022-11-07 | $9.19M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $5.93M 10-Q · filed 2022-08-08 | $8.38M derived: sum of 3 quarters · filed 2023-02-27 | $10.53M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $4.76M 10-Q · filed 2022-05-09 | $7.21M derived: sum of 2 quarters · filed 2023-02-27 | $9.36M derived: sum of 3 quarters · filed 2023-02-27 | $10.94M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $4.61M derived: sum of 2 quarters · filed 2023-02-27 | $6.18M derived: sum of 3 quarters · filed 2023-02-27 | $11.46M 10-K · filed 2023-02-27 |
| 2020-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.73M derived: sum of 2 quarters · filed 2021-11-09 | $9.01M 10-Q · filed 2021-11-09 | $11.14M derived: sum of 4 quarters · filed 2022-03-04 |
| 2020-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $6.86M 10-Q · filed 2021-08-09 | $8.99M derived: sum of 3 quarters · filed 2022-03-04 | $11.54M derived: sum of 4 quarters · filed 2022-03-04 |
| 2020-03-31 | $5.28M 10-Q · filed 2021-05-10 | $7.42M derived: sum of 2 quarters · filed 2022-03-04 | $9.96M derived: sum of 3 quarters · filed 2022-03-04 | $12.04M derived: sum of 4 quarters · filed 2022-03-04 |
| 2019-12-31 | $2.14M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-04 | $4.68M derived: sum of 2 quarters · filed 2022-03-04 | $6.76M derived: sum of 3 quarters · filed 2022-03-04 | $12.75M 10-K/A · filed 2022-03-04 |
| 2019-09-30 | $2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.63M derived: sum of 2 quarters · filed 2020-11-05 | $10.61M 10-Q · filed 2020-11-05 | $12.94M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $8.06M 10-Q · filed 2020-08-06 | $10.39M derived: sum of 3 quarters · filed 2021-03-01 | $13.67M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $5.99M 10-Q · filed 2020-05-07 | $8.31M derived: sum of 2 quarters · filed 2021-03-01 | $11.60M derived: sum of 3 quarters · filed 2021-03-01 | $14.79M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $5.61M derived: sum of 2 quarters · filed 2021-03-01 | $8.80M derived: sum of 3 quarters · filed 2021-03-01 | $15.61M 10-K · filed 2021-03-01 |
| 2018-09-30 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $6.47M derived: sum of 2 quarters · filed 2019-11-12 | $13.29M 10-Q · filed 2019-11-12 | $15.61M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $10.01M 10-Q · filed 2019-08-08 | $12.33M derived: sum of 3 quarters · filed 2020-03-02 | $14.63M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $6.81M 10-Q · filed 2019-05-09 | $9.14M derived: sum of 2 quarters · filed 2020-03-02 | $11.44M derived: sum of 3 quarters · filed 2020-03-02 | $12.69M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $4.62M derived: sum of 2 quarters · filed 2020-03-02 | $5.87M derived: sum of 3 quarters · filed 2020-03-02 | $8.30M 10-K · filed 2020-03-02 |
| 2017-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.55M derived: sum of 2 quarters · filed 2018-11-08 | $5.97M 10-Q · filed 2018-11-08 | $6.47M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.67M 10-Q · filed 2018-08-07 | $4.17M derived: sum of 3 quarters · filed 2019-02-27 | $4.62M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $2.42M 10-Q · filed 2018-05-09 | $2.92M derived: sum of 2 quarters · filed 2019-02-27 | $3.37M derived: sum of 3 quarters · filed 2019-02-27 | $3.90M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $949.00K derived: sum of 2 quarters · filed 2019-02-27 | $1.48M derived: sum of 3 quarters · filed 2019-02-27 | $2.74M 10-K · filed 2019-02-27 |
| 2016-09-30 | $451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $981.00K derived: sum of 2 quarters · filed 2017-11-08 | $2.24M 10-Q · filed 2017-11-08 | $4.49M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $530.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $1.79M 10-Q · filed 2017-08-07 | $4.03M derived: sum of 3 quarters · filed 2018-02-27 | $4.03M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $1.26M 10-Q · filed 2017-05-09 | $3.50M derived: sum of 2 quarters · filed 2018-02-27 | $3.50M derived: sum of 3 quarters · filed 2018-02-27 | $3.50M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.24M derived: sum of 2 quarters · filed 2018-02-27 | $2.24M derived: sum of 3 quarters · filed 2018-02-27 | $2.24M 10-K · filed 2018-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |